References
- Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196. https://doi.org/10.1038/nature01960
- de Lemos ML. 2001. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann. Pharmacother. 35: 11118-11121.
-
Tonetti DA, Zhang Y, Zhao H, Lim SB, Constantinou AI. 2007. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant
$T47D/PKC{\alpha}$ . Nutr. Cancer 58: 1222-1229. - Sharma RA, G escher A J, S teward WP. 2005. Curcumin: the story so far. Eur. J. Cancer 41: 1955-1968. https://doi.org/10.1016/j.ejca.2005.05.009
- Aggarwal BB, Sung B. 2008. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharm. Sci. 30: 85-94.
- Wilken R, Veena MS, Wang MB, Srivatsan ES. 2011. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol. Cancer 10: 12. https://doi.org/10.1186/1476-4598-10-12
- Jayaprakasha GK, Rao LJ, Sakariah KK. 2006. Antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Chem. 98: 720-724. https://doi.org/10.1016/j.foodchem.2005.06.037
-
Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R. 2005. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of
$I{\kappa}B$ kinase and nuclear factor${\kappa}B$ activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104: 879-890. https://doi.org/10.1002/cncr.21216 - Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S. 2008. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J. Gastroenterol. 14: 2003-2009. https://doi.org/10.3748/wjg.14.2003
- Mishra S, Palanivelu K. 2008. The effect of curcumin (turmeric) on Alzheimer's disease: an overview. Ann. Indian Acad. Neurol. 11: 13-19. https://doi.org/10.4103/0972-2327.40220
- Venigalla M, Gyengesi E, Münch G. 2015. Curcumin and apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease. Neural Regen. Res. 10: 1181-1185. https://doi.org/10.4103/1673-5374.162686
- Vyas A, Dandawate P, Padhye S, Ahmad A, Sarkar F. 2013. Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Curr. Pharm. Des. 19: 2047- 2069.
- Youssef KM, El-Sherbeny MA, El-Shafie FS, Farag HA, Al- Deeb OA, Awadalla SA. 2004. Synthesis of curcumin analogues as potential antioxidant, cancer chemopreventive agents. Arch. Pharm. 337: 42-54. https://doi.org/10.1002/ardp.200300763
- Austin MB, Noel JP. 2003. The chalcone synthase superfamily of type III polyketide synthases. Nat. Prod. Rep. 20: 79-110. https://doi.org/10.1039/b100917f
- Flores-Sanchez IJ, Verpoorte R. 2009. Plant polyketide synthase: a fascinating group of enzymes. Plant Physiol. Biochem. 47: 167-174. https://doi.org/10.1016/j.plaphy.2008.11.005
- Katsuyama Y, Matsuzawa M, Funa N, Horinouchi S. 2007. In vitro synthesis of curcuminoids by type III polyketide synthase from Oryza sativa. J. Biol. Chem. 282: 37702-37709. https://doi.org/10.1074/jbc.M707569200
- Katsuyama Y, Kita T, Funa N, Horinouchi S. 2009. Curcuminoid biosynthesis by two type III polyketide synthases in the herb Curcuma longa. J. Biol. Chem. 284: 11160-11170. https://doi.org/10.1074/jbc.M900070200
- Wang J, Guleria S, Koffas MA, Yan Y. 2016. Microbial production of value-added nutraceuticals. Curr. Opin. Biotechnol. 37: 97-104. https://doi.org/10.1016/j.copbio.2015.11.003
- An DG, Cha MN, Nadarajan SP, Kim BG, Ahn J-H. 2016. Bacterial synthesis of four hydroxycinnamic acids. Appl. Biol. Chem. 59: 173-179.
- Kim MJ, Kim B-G, Ahn J-H. 2013. Biosynthesis of bioactive O-methylated flavonoids in Escherichia coli. Appl. Microbiol. Biotechnol. 97: 7195-7204. https://doi.org/10.1007/s00253-013-5020-9
- Lee YJ, Jeon Y, Lee JS, Kim BG, Lee CH, Ahn J-H. 2007. Enzymatic synthesis of phenolic CoAs using 4-coumarate: coenzyme A ligase (4CL) from rice. Bull. Korean Chem. Soc. 28: 365-366. https://doi.org/10.5012/bkcs.2007.28.3.365
- Kim S-K, Kim DH, Kim BG, Jeon YM, Hong BS, Ahn J-H. 2009. Cloning and characterization of the UDP glucose/ galactose epimerases of Oryza sativa. J. Korean Soc. Appl. Biol. Chem. 52: 315-320. https://doi.org/10.3839/jksabc.2009.056
- Kim MK, Jeong W , Kang J , Chong Y. 2011. Significant enhancement in radical-scavenging activity of curcuminoids conferred by acetoxy substituent at the central methylene carbon. Bioorg. Med. Chem. 19: 3793-3800. https://doi.org/10.1016/j.bmc.2011.04.055
- Cochrane FC, Davin LB, Lewis NG. 2004. The Arabidopsis phenylalanine ammonia lyase gene family: kinetic characterization of the four PAL isoforms. Phytochemistry 65: 1157-1564.
- Berner M, Krug D, Gihlmaier C, Vente A, Muller R, Bechthold A. 2006. Genes and enzymes involved in caffeic acid biosynthesis in the actinomycete Saccharothrix espanaensis. J. Bacteriol. 188: 2666-2673. https://doi.org/10.1128/JB.188.7.2666-2673.2006
- Santos CNS, Koffas M, Stephanopoulos G. 2011. Optimization of a heterologous pathway for the production of flavonoids from glucose. Metab. Eng. 13: 392-400. https://doi.org/10.1016/j.ymben.2011.02.002
- Sariaslani FS. 2007. Development of a combined biological and chemical process for production of industrial aromatics from renewable resources. Annu. Rev. Microbiol. 61: 51-69. https://doi.org/10.1146/annurev.micro.61.080706.093248
- Lutke-Eversloh T, Stephanopoulos G. 2007. L-Tyrosine production by deregulated strains of Escherichia coli. Appl. Microbiol. Biotechnol. 75: 103-110. https://doi.org/10.1007/s00253-006-0792-9
- Patnaik R, Liao JC. 1994. Engineering of Escherichia coli central metabolism for aromatic metabolite production with near theoretical yield. Appl. Environ. Microbiol. 60: 3903-3908.
- Rodrigues JL, Araújo RG, Prather KLJ, Kluskens LD, Rodrigues LR. 2015. Production of curcuminoids from tyrosine by a metabolically engineered Escherichia coli using caffeic acid as an intermediate. Biotechnol. J. 10: 599-609. https://doi.org/10.1002/biot.201400637
Cited by
- Recent Advances in the Recombinant Biosynthesis of Polyphenols vol.8, pp.None, 2017, https://doi.org/10.3389/fmicb.2017.02259
- Optimization of fermentation conditions for the production of curcumin by engineered Escherichia coli vol.14, pp.133, 2017, https://doi.org/10.1098/rsif.2017.0470
- Engineering Escherichia coli Co‐Cultures for Production of Curcuminoids From Glucose vol.13, pp.5, 2017, https://doi.org/10.1002/biot.201700576
- Tailoring of microbes for the production of high value plant-derived compounds: From pathway engineering to fermentative production vol.1867, pp.11, 2017, https://doi.org/10.1016/j.bbapap.2019.140262
- Increased Production of Dicinnamoylmethane Via Improving Cellular Malonyl-CoA Level by Using a CRISPRi in Escherichia coli vol.190, pp.1, 2017, https://doi.org/10.1007/s12010-019-03206-8
- A Combinatorial Approach to Optimize the Production of Curcuminoids From Tyrosine in Escherichia coli vol.8, pp.None, 2017, https://doi.org/10.3389/fbioe.2020.00059
- Purification of Curcumin from Ternary Extract-Similar Mixtures of Curcuminoids in a Single Crystallization Step vol.10, pp.3, 2017, https://doi.org/10.3390/cryst10030206